A.n.n.
@fireflyann
Followers
2K
Following
78K
Media
2K
Statuses
21K
volunteer #CRCSM librarian #BRAF & #NRAS FB grps Stage 4 CRC Support & Colon Cancer Stars trials Stage 2/3 pts https://t.co/48vU5493pH
Bay Area, California
Joined June 2009
Started a BRAF Colorectal Cancer Public Library group on Facebook. So many significant trials, research findings, changes to NCCN guidelines, etc. in the last 2 years. Gathering high level research/interviews into 1 place seems wise and useful. #BRAFCRC
4
12
62
RT @TumorBoardTues: #TumorBoardTuesday. 😮We had a rare #ASCO25 with several key🗝️updates in #PancreaticCancer.So to put this in context:.📢J….
0
17
0
RT @Agenus_Bio: Over the weekend at #ESMOGI25, our botensilimab/balstilimab investigational combo presented new MSS #colorectalcancer data,….
0
3
0
RT @AnnaliceGandini: Real-world data on the safety and eficacy of ENCO plus PANI in BRAF V600E mutated mCRC patients who experienced severe….
0
6
0
RT @CathyEngMD: Closing the session is #DrMichaelOverman re: where are with re: immunotherapy in met #crcsm #colorectal #cancer. Excellent….
0
6
0
RT @CathyEngMD: Great talk from Dr. M Overman @MDAndersonNews re: overview on the role of #immunotherapy in #colorectalcancer. Looking for….
0
4
0
Phenomenal session by Dr Michael Overman of @MDAndersonNews . The OG showed up!. Also his session for MSI crc was a.tour de force! To see all that has happened and that a better future is on the brink. Worldwide efforts paying off!.
Great overview by @michael_overman of pMMR #CRC and efforts to modulate for immunotherapy response. Important to learn from negative studies, but also consider that responses might be different in earlier disease stages. #ESMOAmbassadors #ESMOGI25
0
0
0
RT @DrAngelaLamarca: Closing remarks at @myESMO #ESMOGI25. Patient perspective lecture by #Dice. Many steps to improve.👉Early diagnosis- le….
0
6
0
RT @p_ciracimd: #ESMOGI25 was an incredible experience — truly honored to present results from the PARERE study by @FoundationGono in the P….
0
4
0
RT @CathyEngMD: Happening now: Dr. Rene Adam providing an update on metastatic #colorectal #cancer to the liver regarding #Transmet study….
0
1
0
RT @GillSharlene: #ESMOGI25 @myESMO .Proferred paper session #CRC.🚨 Can ctDNA guide surveillance & ⬆️ cure?➡️GALAXY/BESPOKE, FIND & ALTAIR….
0
12
0
RT @MyriamChalabi: Looking forward to the controversy session on organ preservation in dMMR/MSI colon cancers! 🥊 join us in Barcelona room!….
0
5
0
RT @EvelynWongYT: Powerful lecture by @dice_europe Zorana Maravic at #ESMOGI25 exploring patient perspective in #EOCRC. Showcasing how age‑….
0
6
0
Researchers ask what happened to that lady who who participated in TIL trial at @NIH nine years ago. Out there living her best life. 2016 research in NEJM . NY TImes write up. @KRASKickers @DavidHongMD @CrozrX .@nicholasklemen.
0
1
5
RAS Evolution “ Panc CA is a RAS driven disease” @Aiims1742 @myESMO #ESMOGI25 #drugdevelopment #cancer #CancerResearch #pancreaticcancer #cancer #CancerResearch #ESMOAmbassadors @PanCAN
0
0
0
RT @CathyEngMD: @IARC_DIR #Globocan estimates for #earlyonset #colorectal #cancer from 2022-2050 . ⬆️ 27 out of 50 countries . #ESMOGI25 #E….
0
3
0
RT @SuyogCancer: 🔍 GI CANCER CRISIS: THE GAP IS WIDENING.📍 From #ESMOGI25.🧬 GI cancers =.▪️ 26% of global cancer cases.▪️ 34% of cancer dea….
0
19
0
RT @cure_today: Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer #Oncology #ColonCancer #MedTwitter .
0
1
0
RT @RueschCenter: "@CytoDyn Announces Encouraging Survival Data in Patients with metastatic Colorectal Cancer Previously Treated with Leron….
0
4
0
RT @OzmosiHealth: $CYDY CytoDyn reports positive survival results in patients with metastatic colorectal cancer who were previously treated….
0
1
0